245 related articles for article (PubMed ID: 21501493)
1. Expression patterns of microRNAs associated with CML phases and their disease related targets.
Machová Poláková K; Lopotová T; Klamová H; Burda P; Trněný M; Stopka T; Moravcová J
Mol Cancer; 2011 Apr; 10():41. PubMed ID: 21501493
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
Rokah OH; Granot G; Ovcharenko A; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Shpilberg O
PLoS One; 2012; 7(4):e35501. PubMed ID: 22511990
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
4. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia.
Chakraborty C; Sharma AR; Patra BC; Bhattacharya M; Sharma G; Lee SS
Oncotarget; 2016 Jul; 7(27):42683-42697. PubMed ID: 26967056
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Srutova K; Curik N; Burda P; Savvulidi F; Silvestri G; Trotta R; Klamova H; Pecherkova P; Sovova Z; Koblihova J; Stopka T; Perrotti D; Polakova KM
Haematologica; 2018 Dec; 103(12):2016-2025. PubMed ID: 30049824
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
[TBL] [Abstract][Full Text] [Related]
9. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML).
Fei J; Li Y; Zhu X; Luo X
PLoS One; 2012; 7(3):e32834. PubMed ID: 22442671
[TBL] [Abstract][Full Text] [Related]
10. Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.
Zhang J; Jiang Y; Han X; Roy M; Liu W; Zhao X; Liu J
Future Oncol; 2019 Mar; 15(7):763-776. PubMed ID: 30501399
[TBL] [Abstract][Full Text] [Related]
11. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
13. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
[TBL] [Abstract][Full Text] [Related]
14. Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.
Zhu X; Zhao H; Lin Z; Zhang G
Cancer Gene Ther; 2015 Dec; 22(12):573-80. PubMed ID: 26494558
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
16. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis.
Li H; Liu L; Zhuang J; Liu C; Zhou C; Yang J; Gao C; Liu G; Sun C
Mol Genet Genomic Med; 2019 Sep; 7(9):e851. PubMed ID: 31373443
[TBL] [Abstract][Full Text] [Related]
17. Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
Lovat F; Gasparini P; Nigita G; Larkin K; Byrd JC; Minden MD; Andreeff M; Carter BZ; Croce CM
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836616
[TBL] [Abstract][Full Text] [Related]
18. Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia.
Liu Y; Song Y; Ma W; Zheng W; Yin H
Leuk Res; 2013 Mar; 37(3):349-56. PubMed ID: 23287430
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
Xu C; Fu H; Gao L; Wang L; Wang W; Li J; Li Y; Dou L; Gao X; Luo X; Jing Y; Chim CS; Zheng X; Yu L
Oncogene; 2014 Jan; 33(1):44-54. PubMed ID: 23208504
[TBL] [Abstract][Full Text] [Related]
20. microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients.
Mirza MAB; Guru SA; Abdullah SM; Rizvi A; Saxena A
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2379-2383. PubMed ID: 31450909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
